Exclusive Overview by MarketResearchFuture.com of Global Blood Transfusion Diagnostics Market Research Report 2019 to 2023, with respect to region specific market growth and competitive analysis on the basis of major players present in the market. Detail analysis on possible segments and sub segments of the market. Provide country level analysis of the market with respect to the current market size and future prospective
Blood transfusion is defined as the intravenous transfer of blood or blood products. Market Research Future (MRFR) has published a research report about the global blood transfusion diagnostics market that expects an increase for this market at 8.2% CAGR (Compound Annual Growth Rate) during the forecast period between 2017 and 2023. As per value, the market is expected to be worth the US $ 2.45 bn.
Request Sample Copy at https://www.marketresearchfuture.com/sample_request/1126
Observing the market structure, this report offers insights about factors affecting the market growth. Measuring the market size and foretelling the revenue, this reports examines and monitors the competitive developments of market players that include joint ventures, new product developments, mergers and acquisitions, research and developments (R&D), and strategic alliances.
The major reasons pushing the growth of the global blood transfusion diagnostics market include demand for screened blood products, increasing campaigning or awareness programs, increasing in a number of blood transfusion procedures, and rising prevalence of infectious diseases. Demand for blood and blood products is more than the supply, and therefore, a strong chance for market growth always stands.
Segmentation:
The global blood transfusion diagnostics market has been segmented on the basis of blood product, end user, technology, and lastly, region. Based on blood product, this market has been segmented into albumin, immunoglobulin preparations, plasma, platelets, and red blood cells. The segmentation based basis of end users segments the market into blood banks, clinics, hospitals, and laboratories.
The technology-based segmentation segments the market into enzyme-linked immunosorbent assay (ELISA), fluorescence assay, nucleic acid amplification, and western blot. ELISA has been sub-segmented into chemiluminescence immunoassay, colorimetric immunoassay, and fluorescence immunoassay. Nucleic acid amplification has been sub-segmented into Thermomechanical Analysis (TMA) and Real-Time Polymerase chain reaction (PCR).
Regional Analysis:
The regional segmentation of the global blood transfusion diagnostics market can segment the market into regional markets namely the Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA). Due to the availability of advanced medical facilities, awareness programs conducted by the government bodies & non-government organizations government funding for research & development (R&D), increase in the use of nucleic acid amplification test, and the presence of key market players, North America is a bigger regional market than South America. In North America, the USA and Canada are the pivotal country-specific markets. Argentina and Brazil are two strong economies that have the potential to grow as suitable markets in South America.
Browse Complete 200 Pages Premium Research Report Enabled with Respective 30+ Tables and Figures at https://www.marketresearchfuture.com/reports/blood-transfusion-diagnostics-market-1126
Europe is another major regional market. Due to the economic reasons same as the Americas, Western Europe is a bigger market than Eastern Europe. During the forecast period, Europe market can catch up with the Americas market. In Europe, the market is growing due to available skilled healthcare professionals, the collaboration of NGO’s with government bodies, and demand for the improved diagnostics test. The influential country-specific markets in Europe are France, Germany, Italy, Spain, and the UK, followed by the remaining countries of Western Europe and Eastern Europe.
During the forecast period, the Asia Pacific region has been anticipated to emerge as the fastest growing market. Japan is the largest country-specific market in the Asia Pacific region. In this region, factors contributing to market growth are higher demand over limited supplies, demand for new technology adoption, increasing penetration of market leaders in the region, and the increasing number of donors. Other vital country-specific markets in this region are Australia, China, India, and South Korea, followed by the rest of the countries in the Asia Pacific region.
In the MEA region, the market is limited due to poor countries, lack of awareness, lack of advanced medical facilities, low standard of medical facilities, lack of education, lack of healthcare facilities, and most governments not considering healthcare a priority. In this region, the significant country-specific markets are Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates, followed by the remaining countries of the MEA region.
Key Players:
The key players in the global blood transfusion diagnostics market include Abbott Diagnostics (USA), BAG healthcare (Germany), Bio-Rad Laboratories, Inc. (USA), bioMérieux (France), Becton Dickinson & Company (USA), Beckman Coulter Inc. (USA), Biokit (Spain), Clinical Diagnostics Inc. (USA), Diagast (France), DiaSorin (Italy), Fujirebio (Belgium), Grifols (Spain), Hologic/Gen-Probe (USA), Immucor (USA), Ortho Clinical Diagnostics (USA), Ortho Novartis AG (Switzerland), Quidel (USA), Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), AND Thermo Fisher Scientific Inc. (USA).
Latest Industry News
- Quotient Ltd Director Frederick Hallsworth has purchased 10,000 shares of Quotient stock. Quotient Limited is a commercial-stage diagnostics company that develops, manufactures, and commercializes conventional reagent products, useful for the blood grouping in the transfusion diagnostics market worldwide. 6 JAN 2019
- Quotient Limited is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening. 14 DEC 2018
Check Discount at https://www.marketresearchfuture.com/check-discount/1126
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Your information will never be shared with any third party.